Peptides · TIRZ-30

Tirzepatide — 30 mg

$299

Synthetic dual GIP/GLP-1 receptor agonist studied in metabolic research.

In stock

Product notice

For laboratory research use only. Not for human consumption. This product is intended solely for in-vitro research and laboratory experimentation by qualified professionals. Not a drug, food, cosmetic, or dietary supplement. Not approved by the FDA for human or veterinary use.

All products are sold strictly For Research Use Only. Not for human or animal consumption. Not for diagnostic, therapeutic, clinical, or veterinary use. These products have not been evaluated by the FDA for safety or efficacy in humans or animals.

Limited warranty: the product will conform to its Certificate of Analysis at the time of shipment. All other warranties, including merchantability and fitness for a particular purpose, are disclaimed to the maximum extent permitted by law. Not for human or animal use.

✓ Ships within 1 business day, tracked
✓ Third-party HPLC/MS tested
✓ Certificate of Analysis included

About this product

Tirzepatide is a synthetic dual GIP/GLP-1 receptor agonist peptide used in laboratory research on incretin receptor signaling and metabolic models.

Specifications

Contents: 30 mg / vial
Purity: ≥ 98% (HPLC)
Form: Lyophilized powder
Testing: Third-party HPLC & MS
Storage: Store desiccated, away from light
Documentation: Batch Certificate of Analysis

Certificate of Analysis

Batch: TIRZ-30-161-26
Test date: Jul 10, 2026
Purity: 99.5%

View PDF

Tested by an independent third-party laboratory (HPLC/MS). All certificates